Clovis Oncology’s Rubraca® (rucaparib) Met the Primary Endpoint of Significantly Improving …,

“We are pleased with these topline results from the ARIEL4 trial, which confirm the clinical benefit of Rubraca versus chemotherapy, including …, “We are pleased with these topline results from the ARIEL4 trial, which confirm the clinical benefit of Rubraca versus chemotherapy, including …, Read More

Scroll to Top